Genor Biopharma Holdings (FRA:67N0) Pretax Margin %: -155.10% (As of Jun. 2025)


FRA:67N0 Genor Biopharma Holdings Ltd FRA:67N0
22 GF Score
Price €0.34
! 1 Warning Sign
View Full Analysis

What is Genor Biopharma Holdings Pretax Margin %?

Genor Biopharma Holdings FRA:67N0 +3.70% 22 Pretax Margin % is -155.10% as of Jun. 2025. GuruFocus rates FRA:67N0 with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Genor Biopharma Holdings's Pre-Tax Income for the six months ended in Jun. 2025 was €-6.04 Mil. Genor Biopharma Holdings's Revenue for the six months ended in Jun. 2025 was €3.89 Mil. Therefore, Genor Biopharma Holdings's pretax margin for the quarter that ended in Jun. 2025 was -155.10%.

The historical rank and industry rank for Genor Biopharma Holdings's Pretax Margin % or its related term are showing as below:

FRA:67N0' s Pretax Margin % Range Over the Past 10 Years
Min: -29381.76   Med: -4184.87   Max: 24.92
Current: 24.92

FRA:67N0's Pretax Margin % is not ranked
in the Biotechnology industry.
Industry Median: -89.895 vs FRA:67N0: 24.92

Genor Biopharma Holdings  (FRA:67N0) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Genor Biopharma Holdings Pretax Margin % Related Terms

Genor Biopharma Holdings Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Genor Biopharma Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genor Biopharma Holdings Pretax Margin % Chart

Genor Biopharma Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial -29,381.76 0.00 -4,597.73 0.00 -17.03

Genor Biopharma Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -942.15 52.78 -155.10

FRA:67N0 vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Genor Biopharma Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genor Biopharma Holdings Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genor Biopharma Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Genor Biopharma Holdings's Pretax Margin % falls into.


FRA:67N0
22GF Score
Genor Biopharma Holdings Ltd FRA:67N0
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genor Biopharma Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Genor Biopharma Holdings's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-4.608/27.051
=-17.03 %

Genor Biopharma Holdings's Pretax Margin for the quarter that ended in Jun. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-6.038/3.893
=-155.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -155.10% mean?
Genor Biopharma Holdings (FRA:67N0) has a Pretax Margin % of -155.10% as of Jun. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Genor Biopharma Holdings and its competitors.
Is Genor Biopharma Holdings' Pretax Margin % too high?
Genor Biopharma Holdings' current Pretax Margin % is -155.10%. Overall, Genor Biopharma Holdings has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Genor Biopharma Holdings' Pretax Margin % compare to VRTX and REGN?
Genor Biopharma Holdings' Pretax Margin % of -155.10% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Genor Biopharma Holdings and its competitors. Genor Biopharma Holdings's current Pretax Margin % is -155.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genor Biopharma Holdings stock overvalued right now?
Genor Biopharma Holdings (FRA:67N0) has a current Pretax Margin % of -155.10%. The current Pretax Margin % is -155.10%. Genor Biopharma Holdings' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Genor Biopharma Holdings (FRA:67N0), the current Pretax Margin % is -155.10% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genor Biopharma Holdings Business Description

Address 690 Bibo Road, Room 501-02, Building 6, Pudong New District, Shanghai, CHN, 201203
Genor Biopharma Holdings Ltd is a commercial-ready biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. The company is focused on therapeutic areas with substantial unmet medical needs in oncology, autoimmune, and other chronic diseases. Its key drug candidates includes GB491 (lerociclib), a differentiated oral CDK4/6 inhibitor; GB221, a novel HER2 mAb drug candidate; geptanolimab (GB226), GB492, a STING agonist expected to exert synergistic effects in combination with GB226; GB242, an infliximab (Remicade) biosimilar; and GB223, a RANKL, and others.
22GF Score

Get the complete analysis for FRA:67N0

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.34
Price